CI
MRVL icon

Cigna Investments’s Marvell Technology MRVL Stock Holding History

Cigna Investments’s Portfolio MRVL Stock Details MRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.44M Buy
8,206
+84
+1% +$16.8K 0.32% 52
2026
Q1 		$804K Sell
8,122
-151
-2% -$12.7K 0.12% 150
2025
Q4 		$703K Sell
8,273
-212
-2% -$18.6K 0.1% 174
2025
Q3 		$714K Sell
8,485
-93
-1% -$6.84K 0.1% 177
2025
Q2 		$664K Sell
8,578
-89
-1% -$5.55K 0.11% 182
2025
Q1 		$533K Sell
8,667
-89
-1% -$8.63K 0.1% 204
2024
Q4 		$967K Sell
8,756
-101
-1% -$9.38K 0.17% 114
2024
Q3 		$639K Sell
8,857
-156
-2% -$10.8K 0.11% 178
2024
Q2 		$630K Sell
9,013
-62
-0.7% -$4.34K 0.12% 169
2024
Q1 		$643K Sell
9,075
-65
-0.7% -$4.45K 0.12% 171
2023
Q4 		$552K Buy
9,140
+69
+0.8% +$3.73K 0.11% 182
2023
Q3 		$491K Hold
9,071
– – 0.11% 183
2023
Q2 		$543K Hold
9,071
– – 0.1% 197
2023
Q1 		$393K Sell
9,071
-233
-3% -$9.81K 0.08% 277
2022
Q4 		$345K Hold
9,304
– – 0.07% 302
2022
Q3 		$399K Hold
9,304
– – 0.09% 241
2022
Q2 		$405K Buy
9,304
+455
+5% +$25.8K 0.08% 250
2022
Q1 		$634K Buy
8,849
+2,860
+48% +$206K 0.08% 249
2021
Q4 		$524K Sell
5,989
-50
-0.8% -$3.73K 0.04% 356
2021
Q3 		$364K Hold
6,039
– – 0.03% 500
2021
Q2 		$352K Buy
6,039
+843
+16% +$41.2K 0.03% 523
2021
Q1 		$254K Sell
5,196
-1,085
-17% -$53.2K 0.02% 653
2020
Q4 		$299K Sell
6,281
-362
-5% -$15.7K 0.02% 556
2020
Q3 		$264K Sell
6,643
-3,635
-35% -$134K 0.03% 519
2020
Q2 		$360K Buy
+10,278
New +$301K 0.03% 495
2018
Q2 		– Sell
-16,798
Closed -$353K – 779
2018
Q1 		$353K Hold
16,798
– – 0.02% 583
2017
Q4 		$361K Sell
16,798
-287
-2% -$5.85K 0.02% 616
2017
Q3 		$306K Buy
+17,085
New +$284K 0.02% 657

Other funds holding MRVL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cigna Investments's MRVL Position: Q2 2026 in Review

Cigna Investments increased its Marvell Technology (MRVL) stake by 1% in Q2 2026, buying an estimated $16.8K and bringing the position to 8,206 shares worth $2.44M. The position accounts for 0.32% of the portfolio, ranked #52.

Cigna Investments first reported a position in MRVL in Q3 2017 and has held it in 28 quarters since. 2,207 funds tracked by Wall St. Rank hold MRVL as of Q2 2026.

  • Cigna Investments held 8,206 shares of Marvell Technology worth $2.44M as of Q2 2026.
  • Cigna Investments bought 84 Marvell Technology shares in Q2 2026, an estimated $16.8K.
  • Marvell Technology made up 0.32% of Cigna Investments's portfolio in Q2 2026, its #52 holding.
  • Cigna Investments first reported a position in Marvell Technology in Q3 2017 and has held it in 28 quarters since.
  • 2,207 funds tracked by Wall St. Rank held Marvell Technology as of Q2 2026.

Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.